{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:09:14Z","timestamp":1792789754929,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,5,27]],"date-time":"2015-05-27T00:00:00Z","timestamp":1432684800000},"content-version":"vor","delay-in-days":391,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Bristol-Myers Squibb and Pfizer"},{"name":"AstraZeneca, Merck, GlaxoSmithKline, Roche, and Bristol-Myers Squibb"},{"name":"Bristol-Myers Squibb, Merck, and Regado Biosciences"},{"name":"Bristol-Myers Squibb, AstraZeneca, Boehringer Ingelheim, and Daiichi Sankyo"},{"name":"Sanofi-Aventis, Boehringer Ingelheim, Bayer, Bristol-Myers Squibb\/Pfizer, and Daiichi Sankyo"},{"name":"Servier, Sanofi, and New York University School of Medicine"},{"name":"AstraZeneca, Merck, Boehringer Ingelheim, Bristol-Myers Squibb\/Pfizer, and GlaxoSmithKline"},{"name":"Boehringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, Medtronic Foundation, Merck & Co, Pfizer, Sanofi-Aventis, Takeda, and The Medicines Company"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.jacc.2014.02.549","type":"journal-article","created":{"date-parts":[[2014,3,21]],"date-time":"2014-03-21T21:09:10Z","timestamp":1395436150000},"page":"2141-2147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":296,"title":["Major Bleeding in Patients With Atrial\u00a0Fibrillation Receiving Apixaban or Warfarin"],"prefix":"10.1016","volume":"63","author":[{"given":"Elaine M.","family":"Hylek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claes","family":"Held","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato D.","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"De Caterina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M.","family":"Wojdyla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Jansky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe Gabriel","family":"Steg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laine","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Wallentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher B.","family":"Granger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2014.02.549_bib1","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1056\/NEJMsa1103053","article-title":"Emergency hospitalizations for adverse drug events in older Americans","volume":"365","author":"Budnitz","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2014.02.549_bib2","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus\u00a0warfarin\u00a0in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2014.02.549_bib3","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ahj.2009.07.035","article-title":"Apixaban for reduction in stroke and other Thromboembolic events in atrial fibrillation (ARISTOTLE) trial: design and rationale","volume":"159","author":"Lopes","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2014.02.549_bib4","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in nonsurgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jacc.2014.02.549_bib5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"10.1016\/j.jacc.2014.02.549_bib6","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1213\/ane.0b013e31819bceb1","article-title":"The role of tissue factor and factor VIIa in hemostasis","volume":"108","author":"Mackman","year":"2009","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jacc.2014.02.549_bib7","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1160\/TH11-01-0052","article-title":"Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists","volume":"106","author":"Dentali","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacc.2014.02.549_bib8","first-page":"491","article-title":"Rapid warfarin reversal: a 3-factor prothrombin complex concentrate and recombinant factor VIIa cocktail for intracerebral hemorrhage","volume":"116","author":"Sarode","year":"2012","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.jacc.2014.02.549_bib9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1345\/aph.1Q588","article-title":"Dosing of 3-factor prothrombin complex concentrate for international normalized ratio reversal","volume":"46","author":"Baggs","year":"2012","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jacc.2014.02.549_bib10","first-page":"1","article-title":"Risk of thromboembolism, recurrent hemorrhage, and death after warfarin interruption for gastrointestinal bleeding","volume":"17","author":"Witt","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2014.02.549_bib11","doi-asserted-by":"crossref","first-page":"897","DOI":"10.7326\/0003-4819-120-11-199406010-00001","article-title":"Risk factors for intracranial hemorrhage in outpatients taking warfarin","volume":"120","author":"Hylek","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2014.02.549_bib12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0002-9343(98)00198-3","article-title":"Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin","volume":"105","author":"Beyth","year":"1998","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2014.02.549_bib13","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ahj.2005.04.017","article-title":"Clinical classification schemes for predicting haemorrhage: results from the National Registry of Atrial Fibrillation (NRAF)","volume":"151","author":"Gage","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2014.02.549_bib14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jacc.2010.09.024","volume":"57","author":"Lip","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.02.549_bib15","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ahj.2004.11.015","article-title":"Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the AFFIRM study","volume":"149","author":"DiMarco","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2014.02.549_bib16","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1160\/TH11-10-0721","article-title":"Impact of glomerular filtration estimate on bleeding risk in very old patients treated with vitamin K antagonists. Results of EPICA study on the behalf of FCSA (Italian Federation of Anticoagulation Clinics)","volume":"107","author":"Poli","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacc.2014.02.549_bib17","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jacc.2011.03.031","article-title":"A\u00a0new risk scheme to predict warfarin-associated hemorrhage","volume":"58","author":"Fang","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.02.549_bib18","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1136\/bmj.38947.697558.AE","article-title":"Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study","volume":"333","author":"Hallas","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2014.02.549_bib19","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1046\/j.0306-5251.2001.01220.x","article-title":"Upper gastrointestinal bleeding among users of NSAIDs: a population-based cohort study in Denmark","volume":"53","author":"Mellemkjaer","year":"2002","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jacc.2014.02.549_bib20","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1378\/chest.130.5.1390","article-title":"Development of a contemporary bleeding risk model for elderly warfarin recipients","volume":"130","author":"Shireman","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2014.02.549_bib21","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/ajh.2011.254","article-title":"Microalbuminuria is independently associated with deep or infratentorial brain microbleeds in hypertensive adults","volume":"25","author":"Umemura","year":"2012","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jacc.2014.02.549_bib22","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1111\/j.1464-5491.2012.03608.x","article-title":"Prevalence of haematuria positively associated with urine albumin excretion in type 2 diabetes","volume":"29","author":"Shen","year":"2012","journal-title":"Diabet Med"},{"key":"10.1016\/j.jacc.2014.02.549_bib23","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1160\/TH08-08-0530","article-title":"Bleeding complications in patients on anticoagulants who would have been disqualified for clinical trials","volume":"100","author":"Levi","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacc.2014.02.549_bib24","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin\u00a0in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2014.02.549_bib25","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin for nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2014.02.549_bib26","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/archinte.1994.00420130036007","article-title":"Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from\u00a0five randomized controlled trials","volume":"154","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2014.02.549_bib27","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1001\/jama.290.20.2685","article-title":"Anticoagulation therapy for stroke prevention in atrial fibrillation: How well do randomized trials translate into clinical practice?","volume":"290","author":"Go","year":"2003","journal-title":"JAMA"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109714013862?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109714013862?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:07:40Z","timestamp":1760015260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109714013862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":27,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0735109714013862"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2014.02.549","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718321437.793526303","asserted-by":"object"}]},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Major Bleeding in Patients With Atrial\u00a0Fibrillation Receiving Apixaban or Warfarin","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2014.02.549","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}